Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Visilizumab in Treating Patients With Graft-Versus-Host Disease Following Donor Stem Cell Transplantation
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2003
by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting
Study NCT00042744 Information provided by National Cancer Institute (NCI)
First Received on August 5, 2002. Last Updated on February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Graft Versus Host Disease
Additional conditions recognized in this trial
Graft vs Host Disease
More general conditions related to this trial
Immune System Diseases
Interventions listed in this trial
Sponsors listed in this trial
PDL BioPharma, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers